Chengdu Nuoheshenghong Biopharmaceutical

Chengdu Nuoheshenghong Biopharmaceutical is a pharmaceutical manufacturing company and a wholly-owned subsidiary of Beijing Sunshine Novo Pharmaceutical Research Co., Ltd. Established in 2021 and located in Chengdu Tianfu International Bio-town, the company operates as a contract manufacturing organization (CMO/CDMO) and commercial producer. Its manufacturing capabilities include non-terminally sterilized small-volume injections, terminally sterilized small-volume injections, and special formulations such as lipid emulsions and microspheres. The company's product portfolio spans over ten products, including calcitonin salmon injection, icodextrin peritoneal dialysis solution, desmopressin injection, mivacurium chloride injection, and epinephrine injection. It has established a comprehensive quality management and pharmacovigilance system covering the entire lifecycle of drug development and production.